Compass Therapeutics to Participate in Upcoming September Investor Events

Rhea-AI Summary

Compass Therapeutics (Nasdaq: CMPX), a clinical-stage oncology biopharmaceutical company, has announced its participation in four major investor conferences in September 2025:

• Citi's Biopharma Back to School Conference in Boston (Sept 2)
• Cantor Global Healthcare Conference in New York (Sept 3, 2:10 PM ET)
• H.C. Wainwright Global Investment Conference in New York (Sept 8, 11 AM ET)
• Morgan Stanley Global Healthcare Conference in New York (Sept 9, 5:35 PM ET)

All presentations will be archived for 90 days on Compass' Events page.

BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September.

Details are as follows:

Citi’s 2025 Biopharma Back to School Conference
Location: Boston, MA
Date: Tuesday, September 2, 2025

Cantor Global Healthcare Conference
Location: New York, NY
Date: Wednesday, September 3, 2025
Time: 2:10 PM ET
Webcast Link: https://cmpx.info/cantor

H.C. Wainwright 27^th Annual Global Investment Conference
Location: New York, NY
Date: Monday, September 8, 2025
Time: 11 AM ET
Webcast Link: https://journey.ct.events/view/c21a88e1-14c6-46cd-85b8-dbfa550d85a1

Morgan Stanley 23^rd Annual Global Healthcare Conference
Location: New York, NY
Date: Tuesday, September 9, 2025
Time: 5:35 PM ET
Webcast Link: https://cc.webcasts.com/morg007/090825a_js/?entity=89_N2MHE8Q

Virtual/Replay availability: Presentations will be archived for 90 days on Compass’ Events page.

About Compass Therapeutics

Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Compass has built a robust pipeline of novel product candidates designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. The company plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts.

Investor Contact
ir@compasstherapeutics.com

Media Contact
Anna Gifford, Chief of Staff
media@compasstherapeutics.com
617-500-8099

FAQ

When is Compass Therapeutics (CMPX) presenting at the Morgan Stanley Healthcare Conference 2025?

Compass Therapeutics will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9, 2025 at 5:35 PM ET in New York.

How long will Compass Therapeutics' (CMPX) September 2025 conference presentations be available for replay?

All conference presentations will be archived for 90 days on Compass Therapeutics' Events page.

Which investor conferences is Compass Therapeutics (CMPX) attending in September 2025?

Compass is attending four conferences: Citi's Biopharma Back to School Conference, Cantor Global Healthcare Conference, H.C. Wainwright Global Investment Conference, and Morgan Stanley Global Healthcare Conference.

Where can I access the webcast for Compass Therapeutics' (CMPX) Cantor Global Healthcare Conference presentation?

The Cantor Global Healthcare Conference presentation can be accessed via webcast at https://cmpx.info/cantor.